Quick answers
- What is Gentak?
- Gentak is a brand name of Gentamicin sulfate, a prescription medicine. The FDA NDC Directory lists 1 Gentak product in 1 strength and form.
- Who makes Gentak?
- Sciegen Pharms holds the FDA application for Gentak (ANDA064093, approved August 31, 1995).
- Is there a generic or store brand of Gentak?
- Other products of Gentamicin sulfate are listed with the FDA, but none in exactly the same strength and form as a Gentak product.
- Has Gentak been recalled?
- No recall linked to Gentak products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Gentak is
Each Gentak product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Gentamicin sulfate · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| gentamicin sulfate 0.3% ointment (ophthalmic) | Gentak | None listed | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Gentamicin sulfate →
FDA approval
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| ANDA064093 | Sciegen Pharms | August 31, 1995 | 1 |
Companies that list Gentak
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Gentak products.
- Proficient Rx LP1 product
Recalls
No recall linked to Gentak products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.